PR Newswire

The Bulletin

Men's Weekly

.

BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC

Written by PR Newswire

BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC

BioDlink helps Lepu Biopharma win China's marketing approval for EGFR-targeted ADC treating recurrent or metastatic nasopharyngeal carcinoma
This Becotatug Vedotin injection approval is BioDlink's first commercial ADC manufacturing initiative worldwide, validating its complex biologics commercialization capabilities

SUZHOU, China, Nov. 5, 2025 /...

Why Commercial Scaffolding Services Are Critical for Large Scale Projects

Sydney Suburban Living: Combining Style, Security and Functionality

Professional Assistance to a successful Australian relocation

What is a vendor advocate?

Understanding The Benefits Of A Sleep Apnea Mask For Effective Therapy

The Importance Of A 24 Hour Emergency Electrician For Fast And Safe Electrical Response

The Importance Of Vehicle Protection With Bash Plates And Underbody Upgrades

How to Find the Best Off Road Caravans for Australian Adventures

How Rims And Tyres For Sale Sydney Improve Performance, Safety And Driving Confidence

How Huggies Nappies Support Comfort, Absorption And Protection For Babies Of All Ages

How Lighting Shop Perth Stores Help Homeowners Transform Their Spaces With Quality Lighting Solutions

Disability Home Care Services: Empowering Lives Through Quality In-Home Support